Try our Advanced Search for more refined results

Expert Analysis - Rebuttal

Competitive Generic Therapy Exclusivity Offers Benefits

By Stephen Smith, Sailesh Patel and Thomas Rammer (April 25, 2019, 3:31 PM EDT) -- While a recent Law360 guest article addressing competitive generic therapies pointed out potential pitfalls, we believe that generic drug manufacturers can see considerable benefits from CGT with coordinated execution and thoughtful, strategic planning. But as with many opportunity areas, the devil is in the details, as CGT may also present challenges to applicants, particularly those who are not well-prepared or familiar with the statute....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!